Allogene Therapeutics, Inc.(ALLO)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Yoshiyama Annie SVP, Finance | Sale | -9,586 | -7.15%124,517 | $2.31 | $22,144 | View SEC filing | |
| 2026-04-02 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -2,867 | -1.45%195,338 | $2.50 | $7,168 | View SEC filing | |
| 2026-03-18 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -4,835 | -2.38%198,205 | $2.47 | $11,942 | View SEC filing | |
| 2026-03-18 | Chang David D President and CEO | Sale | -47,763 | -0.92%5,150,599 | $2.47 | $117,975 | View SEC filing | |
| 2026-03-04 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -7,132 | -3.39%203,040 | $2.60 | $18,543 | View SEC filing | |
| 2026-02-04 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -7,549 | -3.47%210,172 | $1.73 | $13,060 | View SEC filing | |
| 2026-02-04 | Chang David D President and CEO | Sale | -95,269 | -1.80%5,185,862 | $1.80 | $171,484 | View SEC filing | |
| 2026-02-04 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sale | -24,001 | -1.88%1,252,795 | $1.76 | $42,242 | View SEC filing | |
| 2026-02-04 | Yoshiyama Annie SVP, Finance | Sale | -4,167 | -3.10%130,322 | $1.72 | $7,167 | View SEC filing | |
| 2026-02-04 | Roberts Zachary EVP of R&D | Sale | -35,700 | -5.79%581,166 | $1.77 | $63,189 | View SEC filing | |
| 2026-02-04 | Douglas Earl Martin SVP, General Counsel | Sale | -22,900 | -3.90%564,948 | $1.76 | $40,304 | View SEC filing | |
| 2026-01-23 | Roberts Zachary EVP of R&D | Sale | -26,269 | -4.08%616,866 | $1.56 | $40,980 | View SEC filing | |
| 2025-11-19 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -786 | -0.36%217,721 | $1.22 | $959 | View SEC filing | |
| 2025-10-23 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sale | -36,744 | -2.80%1,276,796 | $1.26 | $46,169 | View SEC filing | |
| 2025-06-12 | MESSEMER DEBORAH M. Director | Sale | -36,885 | -25.56%107,431 | $1.42 | $52,377 | View SEC filing | |
| 2025-04-23 | Yoshiyama Annie SVP, Finance | Sale | -9,601 | -6.84%130,663 | $1.41 | $13,537 | View SEC filing | |
| 2025-03-18 | Chang David D President and CEO | Sale | -46,668 | -0.88%5,276,569 | $1.96 | $91,469 | View SEC filing | |
| 2025-03-18 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | -5,488 | -2.45%218,507 | $1.97 | $10,839 | View SEC filing | |
| 2025-02-20 | MESSEMER DEBORAH M. Director | Sale | -13,313 | -8.45%144,316 | $2.43 | $32,351 | View SEC filing | |
| 2025-02-05 | Douglas Earl Martin SVP, General Counsel | Sale | -6,404 | -1.08%587,848 | $1.71 | $10,951 | View SEC filing | |
| 2025-02-05 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sale | -4,361 | -0.33%1,301,540 | $1.73 | $7,545 | View SEC filing | |
| 2025-02-05 | MOORE TIMOTHY L. Chief Technical Officer | Sale | -14,746 | -5.55%250,713 | $1.71 | $25,216 | View SEC filing | |
| 2025-02-05 | Chang David D President and CEO | Sale | -46,003 | -0.86%5,317,237 | $1.68 | $77,285 | View SEC filing | |
| 2025-02-05 | Roberts Zachary EVP of R&D | Sale | -18,832 | -2.84%643,135 | $1.70 | $32,014 | View SEC filing | |
| 2025-01-23 | Roberts Zachary EVP of R&D | Sale | -27,199 | -5.28%488,054 | $1.78 | $48,414 | View SEC filing |
1-25 of 100